Cargando…
Adjuvant and first line chemotherapy use for endometrial cancer
OBJECTIVE: The objective of this study was to describe patterns of utilization of cytotoxic, hormonal, and immunotherapy in patients with endometrial cancer in the adjuvant setting and at the time of first recurrence. METHODS: We identified patients in the IBM MarketScan database with endometrial ca...
Autores principales: | Knisely, Anne, Huang, Yongmei, Li, Yeran, Prabhu, Vimalanand S., Wright, Jason D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126968/ https://www.ncbi.nlm.nih.gov/pubmed/35620299 http://dx.doi.org/10.1016/j.gore.2022.101002 |
Ejemplares similares
-
Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
por: Otsuka, I, et al.
Publicado: (2002) -
Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
por: Huang, Allan B., et al.
Publicado: (2021) -
Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
por: Kelkar, Sneha S., et al.
Publicado: (2022) -
Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis
por: Rodrigues da Cunha Colombo Bonadio, Renata, et al.
Publicado: (2018) -
The use of neoadjuvant chemotherapy in advanced endometrial cancer
por: Philp, L., et al.
Publicado: (2021)